Onc Now
In this episode of Onc Now, Vernon Sondak reflects on the remarkable evolution of melanoma care over the course of his career. He discusses how breakthroughs in surgery, immunotherapy, targeted therapies, and neoadjuvant treatment have transformed outcomes for patients with melanoma and influenced treatment strategies across oncology. The conversation also explores the challenges of paediatric melanoma, the importance of multidisciplinary collaboration, and the future priorities for melanoma research and patient care.
Apple | Spotify | Amazon Music | Youtube
Speaker bio:
Vernon Sondak is Chair of the Department of Cutaneous Oncology at the H. Lee Moffitt Cancer Center and Research Institute in Tampa, Florida, USA. He has helped develop one of the world’s largest multidisciplinary treatment centres for paediatric melanoma and related conditions. He is internationally recognised for his leadership in the surgical management of melanoma and other cutaneous malignancies, particularly in advancing the use of sentinel lymph node biopsy and lymph node dissection for melanoma staging and treatment.
Timestamps:
00:00 – Introduction
01:30 – Melanoma Care Through the Years
06:52 – Sentinel Node Biopsy Impact Today
12:28 – Paediatric Melanoma Care Challenges
21:45 – Collaboration Driving Melanoma Progress
24:57 – Translating Research into Patient Care
31:30 – Advances in Systemic and Neoadjuvant Therapy
39:06 – Three Wishes for Melanoma Care
Disclaimer: The opinions expressed in this episode belong to the speakers and do not necessarily represent the opinions of EMJ.
